Incidence and outcome of uveitic glaucoma in eyes with intermediate, posterior or panuveitis followed up to 10 years after randomization to fluocinolone acetonide implant or systemic therapy.

PURPOSE: To evaluate long-term risk and outcomes of glaucoma in eyes with intermediate, posterior, and panuveitis managed with systemic or fluocinolone acetonide (0.59 mg, “implant”) therapy. DESIGN: Prospective Follow-up of the Multicenter Uveitis Steroid Treatment (MUST) Clinical Trial Cohort METH...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Ophthalmol
Main Authors: Kempen, John H., Van Natta, Mark L., Friedman, David S., Altaweel, Michael M., Ansari, Husam, Dunn, James P., Elner, Susan G., Holbrook, Janet T., Lim, Lyndell L., Sugar, Elizabeth A., Jabs, Douglas A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606748/
https://ncbi.nlm.nih.gov/pubmed/32628922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2020.06.038
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados